glp 1 gestational diabetes Preconception GLP-1 receptor agonist use may reduce pregnancy risks GLP-1 Agonists For Obesity In

Prolonged exposure may also raise concerns about pancreatitis due to persistent stimulation of exocrine pancreatic tissue [3, 323, 469]

Until recently, therapeutic strategies remained limited to lifestyle interventions, with few pharmacological options demonstrating meaningful clinical benefit

Early clinical trials and real-world studies have demonstrated that Tirzepatide offers superior weight loss results compared to other GLP-1 drugs, positioning it as a highly promising treatment

While the long-term safety and effectiveness of GLP-1RA for other indications like kidney disease and fatty liver still need verification, attention and research investment in GLP-1RAs for obesity and related conditions are keeping increasing, driving further scientific and medical advancements in metabolic diseases